← Back to Search

Risk Reduction Program for Cardiovascular Disease

N/A
Waitlist Available
Led By Eugenia Gianos, MD
Research Sponsored by Northwell Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient with atherosclerotic cardiovascular disease
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

Study Summary

This trial is designed to better understand how to optimize risk factors for young patients with coronary artery disease, with a focus on gender differences. Patients will be part of a 6 month program that includes education, nutritional and exercise instruction, and psychological support. The goal is to improve quality of life and reduce risk factors.

Who is the study for?
The Young Heart Study is for younger adults with coronary artery disease who can participate in exercise and are fluent in English. It's not for those over 60 or with physical limitations that prevent exercising.Check my eligibility
What is being tested?
This study tests a risk reduction program focusing on education, nutrition, exercise, and psychological support to optimize lifestyle factors affecting heart health, especially noting gender differences.See study design
What are the potential side effects?
Since this trial involves lifestyle changes rather than medication, side effects may include muscle soreness from exercise and potential stress from dietary changes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have heart disease caused by hardening of the arteries.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in CV Risk Factor - Blood pressure
Change in CV Risk Factor - Glucometabolic state (A1C)
Change in CV Risk Factor - Overweight/Obesity
+7 more
Secondary outcome measures
Number of Cardiovascular events

Trial Design

1Treatment groups
Experimental Treatment
Group I: Risk Reduction ProgramExperimental Treatment1 Intervention
All participants will receive education about the process of atherosclerosis, risk factors contributing to the disease and specific risk factor goals for each patient for the 6 month program. The patients will then be part of a bimonthly 6 month cardiovascular risk reduction program that will offer both a nutritional program with teaching kitchen component, and exercise instruction lead by an exercise physiologist. Psychological support will be provided to address stress that impairs quality of life, depression or anxiety to fully optimize the lifestyle component.

Find a Location

Who is running the clinical trial?

Northwell HealthLead Sponsor
458 Previous Clinical Trials
470,873 Total Patients Enrolled
3 Trials studying Coronary Artery Disease
1,543 Patients Enrolled for Coronary Artery Disease
Eugenia Gianos, MD5.08 ReviewsPrincipal Investigator - Northwell Health
Northwell Health
5Patient Review
She is both detail-oriented and compassionate. She is willing to take the time to listen to you.

Media Library

Risk Reduction Program Clinical Trial Eligibility Overview. Trial Name: NCT04462159 — N/A
Coronary Artery Disease Research Study Groups: Risk Reduction Program
Coronary Artery Disease Clinical Trial 2023: Risk Reduction Program Highlights & Side Effects. Trial Name: NCT04462159 — N/A
Risk Reduction Program 2023 Treatment Timeline for Medical Study. Trial Name: NCT04462159 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the trial accommodate participants of advanced age?

"This research protocol allows for the inclusion of adults aged 18 to 55."

Answered by AI

Are there vacancies for prospective participants in this trial?

"According to clinicaltrials.gov, this trial is not presently seeking out potential patients. The study was first made available on May 27th 2020 and the information has most recently been updated October 25th 2022. While this investigation is not currently open for enrollment, there are 999 other trials which actively require individuals at present."

Answered by AI

Who is most suited to participate in this investigation?

"To be eligible for this coronary artery disease study, participants must meet the following criteria: individuals aged between 18 and 55 with atherosclerotic cardiovascular conditions. 60 patients are needed in total."

Answered by AI

Who else is applying?

What state do they live in?
New York
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
The Young Heart Study
Eugenia Gianos 2020. "The Young Heart Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04462159.
All > Atherosclerosis
~12 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top